Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?

Prins HJ, van der Werf TS, Boersma WG.

Eur Respir J. 2019 Oct 17;54(4). pii: 1901597. doi: 10.1183/13993003.01597-2019. Print 2019 Oct. No abstract available.

PMID:
31624131
2.

Cost-effectiveness analysis on elderly pneumococcal vaccination in the Netherlands: Challenging the Dutch Health Council's advice.

Zeevat F, van der Schans J, Boersma WG, Boersma C, Postma MJ.

Vaccine. 2019 Oct 8;37(43):6282-6284. doi: 10.1016/j.vaccine.2019.08.051. Epub 2019 Sep 9.

3.

Plasma cytokine profile on admission related to aetiology in community-acquired pneumonia.

Burgmeijer EH, Duijkers R, Lutter R, Bonten MJM, Schweitzer VA, Boersma WG.

Clin Respir J. 2019 Oct;13(10):605-613. doi: 10.1111/crj.13062. Epub 2019 Aug 16.

PMID:
31310442
4.

Aetiology and disease severity are among the determinants of quality of life in bronchiectasis.

Terpstra LC, Biesenbeek S, Altenburg J, Boersma WG.

Clin Respir J. 2019 Aug;13(8):521-529. doi: 10.1111/crj.13054. Epub 2019 Jul 24.

PMID:
31295770
5.

CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions.

Prins HJ, Duijkers R, van der Valk P, Schoorl M, Daniels JMA, van der Werf TS, Boersma WG.

Eur Respir J. 2019 May 23;53(5). pii: 1802014. doi: 10.1183/13993003.02014-2018. Print 2019 May.

PMID:
30880285
6.

Feasibility of a quantitative polymerase chain reaction assay for diagnosing pneumococcal pneumonia using oropharyngeal swabs.

van Schaik ML, Duijkers R, Paternotte N, Jansen R, Rozemeijer W, van der Reijden WA, Boersma WG.

Mol Biol Rep. 2019 Feb;46(1):1013-1021. doi: 10.1007/s11033-018-4558-0. Epub 2018 Dec 19.

PMID:
30569391
7.

Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT).

Wiersinga WJ, Bonten MJ, Boersma WG, Jonkers RE, Aleva RM, Kullberg BJ, Schouten JA, Degener JE, van de Garde EMW, Verheij TJ, Sachs APE, Prins JM.

Neth J Med. 2018 Jan;76(1):4-13.

8.

Nasal gene expression differentiates COPD from controls and overlaps bronchial gene expression.

Boudewijn IM, Faiz A, Steiling K, van der Wiel E, Telenga ED, Hoonhorst SJM, Ten Hacken NHT, Brandsma CA, Kerstjens HAM, Timens W, Heijink IH, Jonker MR, de Bruin HG, Sebastiaan Vroegop J, Pasma HR, Boersma WG, Wielders P, van den Elshout F, Mansour K, Spira A, Lenburg ME, Guryev V, Postma DS, van den Berge M.

Respir Res. 2017 Dec 21;18(1):213. doi: 10.1186/s12931-017-0696-5.

9.

Blood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPD.

Prins HJ, Duijkers R, Lutter R, Daniels JM, van der Valk P, Schoorl M, Kerstjens HA, van der Werf TS, Boersma WG.

Respir Med. 2017 Oct;131:118-124. doi: 10.1016/j.rmed.2017.07.064. Epub 2017 Aug 1.

PMID:
28947018
10.

Effects of daily vitamin D supplementation on respiratory muscle strength and physical performance in vitamin D-deficient COPD patients: a pilot trial.

Rafiq R, Prins HJ, Boersma WG, Daniels JM, den Heijer M, Lips P, de Jongh RT.

Int J Chron Obstruct Pulmon Dis. 2017 Aug 28;12:2583-2592. doi: 10.2147/COPD.S132117. eCollection 2017.

11.

Diagnosing ANCA-associated vasculitis in ANCA positive patients: A retrospective analysis on the role of clinical symptoms and the ANCA titre.

Houben E, Bax WA, van Dam B, Slieker WA, Verhave G, Frerichs FC, van Eijk IC, Boersma WG, de Kuyper GT, Penne EL.

Medicine (Baltimore). 2016 Oct;95(40):e5096.

12.

Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts.

Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE; Alkmaar study group; Ovidius study group.

BMC Infect Dis. 2016 Jun 17;16:299. doi: 10.1186/s12879-016-1641-9.

13.

Pneumococcal urinary antigen test: diagnostic yield and impact on antibiotic treatment.

Laijen W, Snijders D, Boersma WG.

Clin Respir J. 2017 Nov;11(6):999-1005. doi: 10.1111/crj.12453. Epub 2016 Feb 19.

PMID:
26780500
14.

Effects of doxycycline on local and systemic inflammation in stable COPD patients, a randomized clinical trial.

Prins HJ, Daniels JM, Lindeman JH, Lutter R, Boersma WG.

Respir Med. 2016 Jan;110:46-52. doi: 10.1016/j.rmed.2015.10.009. Epub 2015 Oct 30.

15.

Non-cystic fibrosis bronchiectasis: clinical presentation, diagnosis and treatment, illustrated by data from a Dutch Teaching Hospital.

Altenburg J, Wortel K, van der Werf TS, Boersma WG.

Neth J Med. 2015 May;73(4):147-54. Review.

16.

Antibiotic treatment strategies for community-acquired pneumonia in adults.

Postma DF, van Werkhoven CH, van Elden LJ, Thijsen SF, Hoepelman AI, Kluytmans JA, Boersma WG, Compaijen CJ, van der Wall E, Prins JM, Oosterheert JJ, Bonten MJ; CAP-START Study Group.

N Engl J Med. 2015 Apr 2;372(14):1312-23. doi: 10.1056/NEJMoa1406330.

17.

Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials.

Barker AF, O'Donnell AE, Flume P, Thompson PJ, Ruzi JD, de Gracia J, Boersma WG, De Soyza A, Shao L, Zhang J, Haas L, Lewis SA, Leitzinger S, Montgomery AB, McKevitt MT, Gossage D, Quittner AL, O'Riordan TG.

Lancet Respir Med. 2014 Sep;2(9):738-49. doi: 10.1016/S2213-2600(14)70165-1. Epub 2014 Aug 18.

PMID:
25154045
18.

Validation of a visual analogue score (LRTI-VAS) in non-CF bronchiectasis.

Altenburg J, Wortel K, de Graaff CS, van der Werf TS, Boersma WG.

Clin Respir J. 2016 Mar;10(2):168-75. doi: 10.1111/crj.12198. Epub 2014 Sep 4.

PMID:
25103370
19.

Predicting pneumococcal community-acquired pneumonia in the emergency department: evaluation of clinical parameters.

Huijts SM, Boersma WG, Grobbee DE, Gruber WC, Jansen KU, Kluytmans JA, Kuipers BA, Palmen F, Pride MW, Webber C, Bonten MJ; CAP Diagnostics investigators.

Clin Microbiol Infect. 2014 Dec;20(12):1316-22. doi: 10.1111/1469-0691.12740. Epub 2014 Dec 12.

20.

Guideline adherence for empirical treatment of pneumonia and patient outcome. Treating pneumonia in the Netherlands.

Huijts SM, van Werkhoven CH, Boersma WG, Buijs J, Buunk G, Compaijen CJ, van Elde LJ, Gisolf JE, van der Kam R, Kluytmans JA, Kuipers BA, Mager JJ, Oppedijk B, Palmen F, Prins JM, van Reemst B, Silbermann MH, van Tiel FH, van der Wall E, van der Werf TS, Bonten MJ.

Neth J Med. 2013 Dec;71(10):502-7. Review.

21.

Single versus combination antibiotic therapy in adults hospitalised with community-acquired pneumonia.

van der Eerden MM, Boersma WG.

Thorax. 2013 Nov;68(11):1068. doi: 10.1136/thoraxjnl-2013-203994. Epub 2013 Aug 1. No abstract available.

PMID:
23908129
22.

Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques.

Said MA, Johnson HL, Nonyane BA, Deloria-Knoll M, O'Brien KL; AGEDD Adult Pneumococcal Burden Study Team, Andreo F, Beovic B, Blanco S, Boersma WG, Boulware DR, Butler JC, Carratalà J, Chang FY, Charles PG, Diaz AA, Domínguez J, Ehara N, Endeman H, Falcó V, Falguera M, Fukushima K, Garcia-Vidal C, Genne D, Guchev IA, Gutierrez F, Hernes SS, Hoepelman AI, Hohenthal U, Johansson N, Kolek V, Kozlov RS, Lauderdale TL, Mareković I, Masiá M, Matta MA, Miró Ò, Murdoch DR, Nuermberger E, Paolini R, Perelló R, Snijders D, Plečko V, Sordé R, Strålin K, van der Eerden MM, Vila-Corcoles A, Watt JP.

PLoS One. 2013;8(4):e60273. doi: 10.1371/journal.pone.0060273. Epub 2013 Apr 2. Review.

23.

Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.

Altenburg J, de Graaff CS, Stienstra Y, Sloos JH, van Haren EH, Koppers RJ, van der Werf TS, Boersma WG.

JAMA. 2013 Mar 27;309(12):1251-9. doi: 10.1001/jama.2013.1937.

PMID:
23532241
24.

Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia.

Huijts SM, Pride MW, Vos JM, Jansen KU, Webber C, Gruber W, Boersma WG, Snijders D, Kluytmans JA, van der Lee I, Kuipers BA, van der Ende A, Bonten MJ.

Eur Respir J. 2013 Nov;42(5):1283-90. doi: 10.1183/09031936.00137412. Epub 2013 Feb 8.

25.

Transient impairment of reticulocyte hemoglobin content and hepcidin-25 induction in patients with community-acquired pneumonia.

Schoorl M, Snijders D, Schoorl M, Boersma WG, Bartels PC.

Scand J Clin Lab Invest. 2013 Feb;73(1):54-60. doi: 10.3109/00365513.2012.735694. Epub 2012 Oct 25.

PMID:
23098343
26.

Antibiotics in acute exacerbations of COPD: the good, the bad and the ugly.

Boersma WG.

Eur Respir J. 2012 Jul;40(1):1-3. doi: 10.1183/09031936.00211911. No abstract available.

27.

D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial.

Snijders D, Schoorl M, Schoorl M, Bartels PC, van der Werf TS, Boersma WG.

Eur J Intern Med. 2012 Jul;23(5):436-41. doi: 10.1016/j.ejim.2011.10.019. Epub 2011 Nov 21.

PMID:
22726372
28.

SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults.

Wiersinga WJ, Bonten MJ, Boersma WG, Jonkers RE, Aleva RM, Kullberg BJ, Schouten JA, Degener JE, Janknegt R, Verheij TJ, Sachs AP, Prins JM; Dutch Working Party on Antibiotic Policy; Dutch Association of Chest Physicians.

Neth J Med. 2012 Mar;70(2):90-101.

29.

Temporary impairment of reticulocyte haemoglobin content in subjects with community-acquired pneumonia.

Schoorl M, Snijders D, Schoorl M, Boersma WG, Bartels PC.

Int J Lab Hematol. 2012 Aug;34(4):390-5. doi: 10.1111/j.1751-553X.2012.01408.x. Epub 2012 Mar 12.

PMID:
22409253
30.

Evaluation of a new procalcitonin assay for the Siemens ADVIA Centaur with the established method on the B.R.A.H.M.S Kryptor.

Sanders RJ, Schoorl M, Dekker E, Snijders D, Boersma WG, Ten Boekel E.

Clin Lab. 2011;57(5-6):415-20.

PMID:
21755834
31.

CURB-65 pneumonia severity assessment adapted for electronic decision support.

Jones BE, Jones J, Bewick T, Lim WS, Aronsky D, Brown SM, Boersma WG, van der Eerden MM, Dean NC.

Chest. 2011 Jul;140(1):156-163. doi: 10.1378/chest.10-1296. Epub 2010 Dec 16.

32.

Treatment of haemothorax.

Boersma WG, Stigt JA, Smit HJ.

Respir Med. 2010 Nov;104(11):1583-7. doi: 10.1016/j.rmed.2010.08.006. Review.

33.

Immunomodulatory effects of macrolide antibiotics - part 2: advantages and disadvantages of long-term, low-dose macrolide therapy.

Altenburg J, de Graaff CS, van der Werf TS, Boersma WG.

Respiration. 2011;81(1):75-87. doi: 10.1159/000320320. Epub 2010 Aug 21. Review.

34.

Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms.

Altenburg J, de Graaff CS, van der Werf TS, Boersma WG.

Respiration. 2011;81(1):67-74. doi: 10.1159/000320319. Epub 2010 Aug 21. Review.

35.

Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD.

Daniels JM, Schoorl M, Snijders D, Knol DL, Lutter R, Jansen HM, Boersma WG.

Chest. 2010 Nov;138(5):1108-15. doi: 10.1378/chest.09-2927. Epub 2010 Jun 24.

PMID:
20576731
36.

Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial.

Snijders D, Daniels JM, de Graaff CS, van der Werf TS, Boersma WG.

Am J Respir Crit Care Med. 2010 May 1;181(9):975-82. doi: 10.1164/rccm.200905-0808OC. Epub 2010 Feb 4.

PMID:
20133929
37.

Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.

Daniels JM, Snijders D, de Graaff CS, Vlaspolder F, Jansen HM, Boersma WG.

Am J Respir Crit Care Med. 2010 Jan 15;181(2):150-7. doi: 10.1164/rccm.200906-0837OC. Epub 2009 Oct 29.

PMID:
19875685
38.

Sputum colour reported by patients is not a reliable marker of the presence of bacteria in acute exacerbations of chronic obstructive pulmonary disease.

Daniels JM, de Graaff CS, Vlaspolder F, Snijders D, Jansen HM, Boersma WG.

Clin Microbiol Infect. 2010 Jun;16(6):583-8. doi: 10.1111/j.1469-0691.2009.02892.x. Epub 2009 Jul 20.

39.

Impact of macrolide therapy on mortality in severe sepsis caused by pneumonia.

van der Eerden MM, Boersma WG.

Eur Respir J. 2009 Aug;34(2):521. doi: 10.1183/09031936.00036209. No abstract available.

40.

A turbulent cause of bilateral pneumonia.

Bathoorn E, Heitbrink MA, Reichert CL, Boersma WG.

Eur Respir J. 2009 Jun;33(6):1513-6. doi: 10.1183/09031936.00077508. No abstract available.

41.

Rituximab in life threatening antisynthetase syndrome.

Vandenbroucke E, Grutters JC, Altenburg J, Boersma WG, ter Borg EJ, van den Bosch JM.

Rheumatol Int. 2009 Oct;29(12):1499-502. doi: 10.1007/s00296-009-0859-x. Epub 2009 Feb 1.

PMID:
19184665
42.

Detection of respiratory viruses and Legionella spp. by real-time polymerase chain reaction in patients with community acquired pneumonia.

Diederen BM, Van Der Eerden MM, Vlaspolder F, Boersma WG, Kluytmans JA, Peeters MF.

Scand J Infect Dis. 2009;41(1):45-50. doi: 10.1080/00365540802448799.

PMID:
18821175
43.

A patient with endobronchial BALT lymphoma successfully treated with radiotherapy.

Hashemi SM, Heitbrink MA, Jiwa M, Boersma WG.

Respir Med. 2007 Oct;101(10):2227-9. Epub 2007 Jul 5.

44.

Incidence and completeness of notification of Legionnaires' disease in The Netherlands: covariate capture-recapture analysis acknowledging regional differences.

Van Hest NA, Hoebe CJ, Den Boer JW, Vermunt JK, Ijzerman EP, Boersma WG, Richardus JH.

Epidemiol Infect. 2008 Apr;136(4):540-50. Epub 2007 Jun 22.

45.

[Legionella outbreak in Amsterdam: a cooling tower as the source].

Boersma WG, Snijders D.

Ned Tijdschr Geneeskd. 2006 Nov 4;150(44):2456-7; author reply 2457. Dutch. No abstract available.

PMID:
17131708
46.

Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL.

Boersma WG, Erjavec Z, van der Werf TS, de Vries-Hosper HG, Gouw AS, Manson WL.

Respir Med. 2007 Feb;101(2):317-25. Epub 2006 Jun 13.

47.

[Pharyngitis with necrotising pneumonia caused by Arcanobacterium haemolyticum].

van der Eerden MM, de Graaff CS, Boersma WG, Vlaspolder F.

Ned Tijdschr Geneeskd. 2006 May 20;150(20):1139-42. Dutch.

PMID:
16756228
48.

[Migrating pulmonary infiltrates due to a foreign body].

Koster GJ, Boersma WG, de Graaff CS.

Ned Tijdschr Geneeskd. 2005 Dec 17;149(51):2868-72. Dutch.

PMID:
16398170
49.

Reliability of radiographic findings and the relation to etiologic agents in community-acquired pneumonia.

Boersma WG, Daniels JM, Löwenberg A, Boeve WJ, van de Jagt EJ.

Respir Med. 2006 May;100(5):926-32. Epub 2005 Dec 6.

50.

[Guideline 'Diagnosis and treatment of community-acquired pneumonia' from the Dutch Thoracic Society].

Aleva RM, Boersma WG; Dutch Thoracic Society.

Ned Tijdschr Geneeskd. 2005 Nov 5;149(45):2501-7. Dutch.

PMID:
16304887

Supplemental Content

Loading ...
Support Center